VirG-specific antibodies provide cross-protection against Shigella infections

This research highlights the potential of VirG-specific antibodies to mediate antimicrobial functions and offer cross-protection against Shigella species, a major cause of diarrheal diseases and child mortality. The study demonstrates that immunization with VirG-derived constructs induces strong and durable IgG responses, and passive transfer of these antibodies provides significant protection in animal models. This approach may overcome the limitations of current vaccine candidates that are restricted by serotype specificity.

Originally published by gnews